4//SEC Filing
Rosett Max 4
Accession 0001415889-24-002121
CIK 0001472012other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 8:53 PM ET
Size
5.5 KB
Accession
0001415889-24-002121
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Rosett Max
Chief Financial Officer
Transactions
- Award
Stock option (right to buy)
2024-01-31+175,000→ 175,000 totalExercise: $16.57Exp: 2034-01-30→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the options vest on January 31, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.
Documents
Issuer
Immunome Inc.
CIK 0001472012
Entity typeother
Related Parties
1- filerCIK 0001994071
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 8:53 PM ET
- Size
- 5.5 KB